Glucagon-like peptide-1 receptor agonists and sodium-glucose co-transporter-2 inhibitors as combination therapy for type 2 diabetes: A systematic review and meta-analysis..
Diabetes Obes Metab. 22(10), 1857-1868.
(2020). GLP-1 receptor agonists for cardiovascular outcomes with and without metformin. A systematic review and meta-analysis of cardiovascular outcomes trials..
Diabetes Res Clin Pract. 177, 108921.
(2021). GLP-1 receptor agonists and SGLT2 inhibitors for older people with type 2 diabetes: A systematic review and meta-analysis..
Diabetes Res Clin Pract. 174, 108737.
(2021). Glomerular filtration rate is an independent factor of mortality in patients with decompensated cirrhosis..
Hepatol Res. 44(10), E145-55.
(2014). Glomerular filtration rate estimation in patients with type 2 diabetes: creatinine- or cystatin C-based equations?.
Diabetologia. 54(12), 2987-94.
(2011). Global variation in anastomosis and end colostomy formation following left-sided colorectal resection..
BJS Open. 3(3), 403-414.
(2019). Global specialized stroke care delivery models..
J Vasc Nurs. 34(1), 2-11.
(2016). Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: a systematic analysis for the Global Burden of Disease Study 2016..
Lancet. 390(10100), 1084-1150.
(2017). Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017..
Lancet. 392(10159), 1789-1858.
(2018). Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition..
Lancet. 386(10009), 2145-91.
(2015). Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013..
Lancet. 386(10010), 2287-323.
(2015). Global, regional, and national age-sex-specific mortality and life expectancy, 1950-2017: a systematic analysis for the Global Burden of Disease Study 2017..
Lancet. 392(10159), 1684-1735.
(2018). Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013..
Lancet. 385(9963), 117-71.
(2015). Global prevalence and major risk factors of diabetic retinopathy..
Diabetes Care. 35(3), 556-64.
(2012). Global patient outcomes after elective surgery: prospective cohort study in 27 low-, middle- and high-income countries..
Br J Anaesth. 117(5), 601-609.
(2016). Global microRNA profiling in favorable prognosis subgroups of cancer of unknown primary (CUP) demonstrates no significant expression differences with metastases of matched known primary tumors..
Clin Exp Metastasis. 30(4), 431-9.
(2013). Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium..
Lancet Infect Dis. 19(12), e405-e421.
(2019). Global economic burden of unmet surgical need for appendicitis..
Br J Surg. 109(10), 995-1003.
(2022). Global consensus recommendations on menopause in the workplace: A European Menopause and Andropause Society (EMAS) position statement..
Maturitas. 151, 55-62.
(2021). Global cardiovascular protection in chronic kidney disease..
Nat Rev Cardiol. 13(10), 603-8.
(2016). Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019..
Lancet. 396(10258), 1223-1249.
(2020). Global avian influenza outbreaks 2010-2016: a systematic review of their distribution, avian species and virus subtype..
Syst Rev. 7(1), 17.
(2018). Global and regional molecular epidemiology of HIV-1, 1990-2015: a systematic review, global survey, and trend analysis..
Lancet Infect Dis. 19(2), 143-155.
(2019). Global and Regional Estimates for Subtype-Specific Therapeutic and Prophylactic HIV-1 Vaccines: A Modeling Study..
Front Microbiol. 12, 690647.
(2021). Global and regional epidemiology of HIV-1 recombinants in 1990-2015: a systematic review and global survey..
Lancet HIV. 7(11), e772-e781.
(2020).